Cue Biopharma Inc — Balance Sheet (NASDAQ:CUE) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Total assets 99.53 M83.4 M91.28 M61.53 M32.19 M Total liabilities 20.62 M17.91 M25.6 M24.45 M14.69 M Total equity 78.91 M65.49 M65.68 M37.09 M17.5 M Total liabilities & shareholders' equities 99.53 M83.4 M91.28 M61.53 M32.19 M Total debt ——8.11 M4.24 M37 K Net debt ——-68.18 M-44.27 M-22.42 M

Notizie

Cue Biopharma fissa il prezzo dell’offerta pubblica di 10 milioni di dollari a 0,28 dollari per azione

Cue Biopharma prices $10 million public offering at $0.28 per share

Azioni Cue Biopharma crollano dopo l’annuncio di offerta pubblica

Cue Biopharma stock tumbles on public offering announcement

Cue Biopharma launches public offering of common stock and warrants

Cue Biopharma: Citizens riconferma rating Outperform con target di $2,00

Cue Biopharma stock rating reiterated at Market Outperform by Citizens

ImmunoScape ottiene licenza per tecnologia Cue Biopharma per nuova terapia contro il cancro

ImmunoScape licenses Cue Biopharma technology for novel cancer therapy

Gli EPS di Cue Biopharma hanno battuto le aspettative per 0,02$, il fatturato appena sotto le previsioni

Cue Biopharma earnings beat by $0.02, revenue fell short of estimates

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Lags Revenue Estimates